Evaluation of the Indirect and Nonmedical Impacts of Generalized Myasthenia Gravis on Patients and Caregivers (P9-11.032)
Assess indirect and nonmedical costs for US patients with generalized myasthenia gravis (gMG) and caregivers.
Authors
- Carol J. Thiele (ORCID: https://orcid.org/0000-0003-2869-7690)
- Susan dosReis (ORCID: https://orcid.org/0000-0003-2210-6650)
- Christina M. Ramirez (ORCID: https://orcid.org/0000-0002-8435-0416)
- Pushpa Narayanaswami (ORCID: https://orcid.org/0000-0002-9412-7349)
- Kelly Gwathmey (ORCID: https://orcid.org/0000-0002-7589-8826)
- Mayvis Rebeira (ORCID: https://orcid.org/0000-0003-0915-3671)
- Karen W L Yee (ORCID: https://orcid.org/0000-0002-2572-9952)
- Taylor Schwartz
- Nicole Betor
- Allison Foss
- Jamie Sullivan
- Olivia Hunt
Institutions
- Hadassah Medical Center (IL)
- AstraZeneca (Brazil) (BR)
- Alexion Pharma (Switzerland) (CH)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000208752
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00